These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 25207680)

  • 1. Metabolic syndrome definitions and components in predicting major adverse cardiovascular events after kidney transplantation.
    Prasad GV; Huang M; Silver SA; Al-Lawati AI; Rapi L; Nash MM; Zaltzman JS
    Transpl Int; 2015 Jan; 28(1):79-88. PubMed ID: 25207680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abdominal obesity is the most significant metabolic syndrome component predictive of cardiovascular events in chronic hemodialysis patients.
    Wu CC; Liou HH; Su PF; Chang MY; Wang HH; Chen MJ; Hung SY
    Nephrol Dial Transplant; 2011 Nov; 26(11):3689-95. PubMed ID: 21357211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is metabolic syndrome a useless category in subjects with high cardiovascular risk? Results from a cohort study in men with erectile dysfunction.
    Corona G; Monami M; Rastrelli G; Melani C; Balzi D; Sforza A; Forti G; Mannucci E; Maggi M
    J Sex Med; 2011 Feb; 8(2):504-11. PubMed ID: 21091887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study.
    Hunt KJ; Resendez RG; Williams K; Haffner SM; Stern MP;
    Circulation; 2004 Sep; 110(10):1251-7. PubMed ID: 15326061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic syndrome affects midterm outcome after coronary artery bypass grafting.
    Angeloni E; Melina G; Benedetto U; Refice S; Capuano F; Roscitano A; Comito C; Sinatra R
    Ann Thorac Surg; 2012 Feb; 93(2):537-44. PubMed ID: 22197615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of the metabolic syndrome and its components in the prediction of incident cardiovascular disease: a prospective cohort study.
    Knuiman MW; Hung J; Divitini ML; Davis TM; Beilby JP
    Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):235-41. PubMed ID: 19238082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of different definitions of metabolic syndrome in predicting cardiovascular events in a cohort of non-diabetic Tehranian adults.
    Hosseinpanah F; Asghari G; Barzin M; Golkashani HA; Azizi F
    Int J Cardiol; 2013 Sep; 168(1):369-74. PubMed ID: 23041003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trajectories of entering the metabolic syndrome: the framingham heart study.
    Franco OH; Massaro JM; Civil J; Cobain MR; O'Malley B; D'Agostino RB
    Circulation; 2009 Nov; 120(20):1943-50. PubMed ID: 19884471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Framingham risk score and novel cardiovascular risk factors underpredict major adverse cardiac events in kidney transplant recipients.
    Silver SA; Huang M; Nash MM; Prasad GV
    Transplantation; 2011 Jul; 92(2):183-9. PubMed ID: 21558986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns.
    Wang J; Ruotsalainen S; Moilanen L; Lepistö P; Laakso M; Kuusisto J
    Eur Heart J; 2007 Apr; 28(7):857-64. PubMed ID: 17303589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular disease in live related renal transplantation.
    Kaul A; Sharm RK; Gupta A; Sinha N; Singh U
    J Assoc Physicians India; 2011 Nov; 59():715-8. PubMed ID: 22616338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-existing diabetes significantly increases the risk of graft failure and mortality following renal transplantation.
    Taber DJ; Meadows HB; Pilch NA; Chavin KD; Baliga PK; Egede LE
    Clin Transplant; 2013; 27(2):274-82. PubMed ID: 23383719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of pre-operative electrocardiographic abnormalities and cardiovascular risk factors on patient and graft survival following renal transplantation.
    Woo YM; McLean D; Kavanagh D; Ward L; Aitken S; Miller GJ; Egan P; Hughes K; Clark L; Carswell K; Morris ST; Northridge DB; Rodger RS; Jardine AG
    J Nephrol; 2002; 15(4):380-6. PubMed ID: 12243367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morbid obesity is not an independent predictor of graft failure or patient mortality after kidney transplantation.
    Pieloch D; Dombrovskiy V; Osband AJ; Lebowitz J; Laskow DA
    J Ren Nutr; 2014 Jan; 24(1):50-7. PubMed ID: 24070588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and predictors of early cardiovascular events after kidney transplantation: evaluation of pre-transplant cardiovascular work-up.
    Delville M; Sabbah L; Girard D; Elie C; Manceau S; Piketty M; Martinez F; Méjean A; Legendre C; Sberro-Soussan R
    PLoS One; 2015; 10(6):e0131237. PubMed ID: 26107641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating Angiopoietin-2 levels predict mortality in kidney transplant recipients: a 4-year prospective case-cohort study.
    Molnar MZ; Kümpers P; Kielstein JT; Schiffer M; Czira ME; Ujszaszi A; Kovesdy CP; Mucsi I
    Transpl Int; 2014 Jun; 27(6):541-52. PubMed ID: 24628855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic syndrome in the prediction of cardiovascular events: the potential additive role of hsCRP and adiponectin.
    Santaniemi M; Ukkola O; Malo E; Bloigu R; Kesäniemi YA
    Eur J Prev Cardiol; 2014 Oct; 21(10):1242-8. PubMed ID: 23787794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of metabolic syndrome on future cardiovascular events in patients with first acute myocardial infarction.
    Selcuk H; Temizhan A; Selcuk MT; Sen T; Maden O; Tekeli S; Sasmaz A
    Coron Artery Dis; 2009 Sep; 20(6):370-5. PubMed ID: 19609207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic syndrome: A predictor of adverse outcomes after carotid revascularization.
    Protack CD; Bakken AM; Xu J; Saad WA; Lumsden AB; Davies MG
    J Vasc Surg; 2009 May; 49(5):1172-80.e1; discussion 1180. PubMed ID: 19394545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metabolic syndrome, insulin resistance, and cardiovascular risk in diabetic and nondiabetic patients.
    Saely CH; Aczel S; Marte T; Langer P; Hoefle G; Drexel H
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5698-703. PubMed ID: 16091486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.